CN Stock MarketDetailed Quotes
300391 Changjiang Pharmaceutical Group
- 7.07
- -0.10-1.39%
Market Closed Dec 13 15:00 CST
2.48BMarket Cap-3.69P/E (TTM)
7.31High7.03Low363.68KlotVolume7.11Open7.17Pre Close260.97MTurnover10.38%Turnover RatioLossP/E (Static)350.34MShares8.3452wk High176.75P/B2.48BFloat Cap2.2452wk Low8.60Limit Up350.34MShs Float28.95Historical High5.74Limit Down3.91%Amplitude2.24Historical Low--Dividend TTM7.18Avg Price201.89KlotAsk--Div YieldTTM100Lot Size152.05KlotBid
Changjiang Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -51.27%6.74M | -21.35%10.06M | -32.30%8.55M | -13.00%15.2M | 47.42%13.83M | -91.87%12.79M | -93.73%12.63M | -83.77%17.47M | -91.93%9.38M | 38.98%157.26M |
| Notes receivable and accounts receivable | -3.30%1.52B | 24.41%1.52B | 13.49%1.6B | 14.72%1.64B | 6.87%1.57B | -10.97%1.22B | -1.54%1.41B | 3.32%1.43B | 23.19%1.47B | 12.45%1.37B |
| -Notes receivable | ---- | ---- | ---- | --100K | ---- | ---- | ---- | ---- | -96.26%80K | --30.69M |
| -Accounts receivable | -3.30%1.52B | 24.41%1.52B | 13.49%1.6B | 14.71%1.64B | 6.88%1.57B | -8.93%1.22B | -1.41%1.41B | 3.70%1.43B | 23.40%1.47B | 9.93%1.34B |
| Other receivables (including interest and dividends) | 4.01%73.94M | 32.28%73.22M | 550.29%259.18M | 676.28%243.94M | 47.00%71.09M | 30.61%55.35M | -7.12%39.86M | -40.39%31.42M | -80.96%48.36M | -73.40%42.38M |
| -Other receivable | ---- | 32.28%73.22M | ---- | ---- | ---- | 30.61%55.35M | ---- | -40.39%31.42M | ---- | -73.40%42.38M |
| Contractual assets | -79.38%5.28M | -95.38%845.31K | -62.15%6.92M | -62.15%6.92M | 39.73%25.59M | -0.18%18.28M | 71.50%18.28M | 71.50%18.28M | -89.95%18.31M | -91.97%18.31M |
| Advance payment | -28.19%126.69M | -68.48%126.37M | -38.62%145.42M | -6.10%120.76M | 104.65%176.42M | 10.70%400.97M | -8.80%236.93M | 3.82%128.6M | -25.61%86.21M | 104.07%362.2M |
| Inventories | -20.19%45.42M | -60.41%54.15M | -24.98%53.7M | -12.80%51.86M | -52.58%56.91M | -1.34%136.77M | -54.99%71.59M | -69.55%59.47M | -39.21%120.02M | -47.51%138.63M |
| Receivable financing | ---- | 171.43%95K | ---- | 32.28%238.11K | 359.40%3.57M | -99.93%35K | -99.19%827.08K | -99.86%180K | -99.44%776.19K | -48.61%50.69M |
| Other current assets | -3.65%44.07M | -28.36%50.41M | -13.53%43.38M | -11.88%50.45M | -15.03%45.75M | 38.87%70.36M | 25.97%50.16M | 1.42%57.25M | 78.24%53.83M | 78.10%50.67M |
| Total current assets | -7.27%1.82B | -4.23%1.84B | 15.05%2.12B | 22.22%2.13B | 8.70%1.97B | -12.59%1.92B | -18.12%1.84B | -15.41%1.74B | -18.83%1.81B | -4.24%2.19B |
| Non Current assets | ||||||||||
| Fixed assets | ---- | -11.54%748.72M | ---- | ---- | ---- | -21.41%846.42M | ---- | -20.34%882.47M | ---- | 99.06%1.08B |
| Constru in process | ---- | 0.54%189.25M | ---- | ---- | ---- | 7.25%188.23M | ---- | 4.47%177.94M | ---- | -71.92%175.5M |
| Productive biological assets | ---- | ---- | ---- | -7.47%1.95M | -6.93%1.99M | -6.53%2.03M | -5.89%2.07M | -5.58%2.11M | -11.26%2.14M | -10.25%2.17M |
| Intangible assets | -2.67%97.2M | -2.70%97.83M | 139.39%98.5M | 137.60%99.18M | 135.27%99.86M | 78.46%100.54M | -32.28%41.15M | -33.39%41.74M | -33.70%42.45M | -14.51%56.34M |
| Goodwill | -66.32%208.63M | -66.32%208.63M | -65.05%236.07M | -65.05%236.07M | -11.72%619.51M | -11.72%619.51M | -3.75%675.43M | -3.75%675.43M | 0.00%701.73M | 0.00%701.73M |
| Long deferred expense | ---- | ---- | ---- | ---- | ---- | -98.46%189.46K | -97.86%270.86K | -97.30%360.29K | -96.76%441.69K | -11.20%12.27M |
| Deferred tax assets | -6.22%16.47M | -64.04%16.47M | -59.52%16.47M | -58.63%16.47M | -52.04%17.56M | 40.14%45.79M | -39.47%40.68M | -39.89%39.8M | -39.71%36.61M | -43.36%32.67M |
| Usufruct assets | -17.28%6.1M | -38.24%6.45M | -32.33%8.78M | -23.57%11.77M | -59.26%7.37M | -51.14%10.44M | -45.09%12.98M | -41.14%15.39M | --18.09M | --21.38M |
| Other non current assets | -69.80%813.5K | 86.07%5.01M | -51.96%813.5K | 78.51%3.02M | -63.43%2.69M | -63.43%2.69M | -23.23%1.69M | -66.66%1.69M | -74.03%7.36M | -63.97%7.36M |
| Total non current assets | -28.64%1.27B | -29.93%1.27B | -28.16%1.31B | -28.30%1.32B | -4.65%1.78B | -12.97%1.82B | -14.08%1.82B | -14.78%1.84B | -9.14%1.86B | 2.88%2.09B |
| Total assets | -17.41%3.09B | -16.74%3.11B | -6.44%3.43B | -3.71%3.45B | 1.93%3.74B | -12.78%3.73B | -16.16%3.67B | -15.09%3.58B | -14.19%3.67B | -0.90%4.28B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -57.93%199.98M | -56.65%219.72M | -59.25%214.98M | -61.91%205.12M | -13.95%475.4M | -23.05%506.91M | -15.66%527.57M | 8.71%538.5M | 21.60%552.46M | 33.58%658.73M |
| Notes payable and accounts payable | 7.83%326.37M | 11.96%326.97M | 45.02%361.12M | 79.66%358.51M | 21.40%302.68M | -44.86%292.05M | -57.75%249.02M | -68.96%199.55M | -54.95%249.32M | -6.90%529.63M |
| -Notes payable | -97.75%432.61K | -96.46%1.49M | -57.76%2.8M | 493.26%17.46M | 255.38%19.26M | -64.05%42.21M | -94.82%6.62M | -97.23%2.94M | -95.27%5.42M | 25.15%117.4M |
| -Accounts payable | 15.00%325.94M | 30.27%325.48M | 47.82%358.33M | 73.47%341.04M | 16.20%283.42M | -39.39%249.84M | -47.47%242.4M | -63.35%196.61M | -44.43%243.9M | -13.23%412.22M |
| Contract liabilities | -57.57%14.44M | -47.54%13.74M | -31.47%13.57M | 17.08%16.95M | 80.11%34.02M | 23.24%26.19M | 42.41%19.81M | 9.09%14.48M | -12.69%18.89M | 35.00%21.25M |
| Salaries payable | -0.21%25.91M | 13.17%26.6M | -0.76%22.11M | -10.86%18.52M | 48.27%25.96M | 9.90%23.5M | 9.28%22.28M | -22.67%20.78M | -8.49%17.51M | -1.72%21.38M |
| Taxs payable | -8.24%124.79M | -5.88%124.96M | -5.95%124.88M | -3.59%127.46M | 5.44%135.99M | 2.10%132.77M | 1.87%132.78M | 6.26%132.2M | -8.98%128.98M | 0.09%130.04M |
| Other payable (including interest and dividends) | 39.03%1.03B | 48.87%961.98M | 71.94%1.12B | 84.00%1.04B | 79.11%742.57M | -18.12%646.19M | -13.28%650.13M | -26.49%567.45M | -56.25%414.59M | -19.28%789.22M |
| -Interest payable | --26.02M | --23.89M | --28.74M | --20.44M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other payable | ---- | 45.17%938.09M | ---- | ---- | ---- | -18.12%646.19M | ---- | -26.49%567.45M | ---- | -19.25%789.22M |
| Non current liabilities due within one year | 77.74%106.96M | 57.79%106.96M | 162.73%106.38M | 53.21%108.03M | 68.34%60.18M | 118.36%67.78M | 29.11%40.49M | 124.96%70.51M | --35.75M | --31.04M |
| Other current liabilities | -87.94%538.08K | -82.20%538.08K | -71.55%553.15K | 8.66%1.72M | 239.87%4.46M | -62.33%3.02M | 15.70%1.94M | -58.88%1.59M | -46.63%1.31M | 333.39%8.03M |
| Total current liabilities | 2.81%1.83B | 4.89%1.78B | 19.31%1.96B | 21.71%1.88B | 25.55%1.78B | -22.42%1.7B | -23.97%1.64B | -26.77%1.55B | -33.71%1.42B | -0.89%2.19B |
| Current liabilities | ||||||||||
| Long term loan | 51.52%480.9M | 62.19%510.9M | 47.17%504.48M | 54.76%518.89M | -13.05%317.39M | -21.25%315M | -6.88%342.79M | 7.97%335.29M | 8.96%365M | 19.40%400M |
| Long term account payable | ---- | ---- | ---- | ---- | ---- | -99.65%4.27K | ---- | -99.55%538.33K | ---- | -98.95%1.23M |
| Estimate liabilities | -55.91%12.95M | 174.26%11.04M | -83.19%676.45K | -83.19%676.45K | --29.38M | -68.55%4.03M | -69.70%4.03M | -65.28%4.03M | ---- | 1.48%12.8M |
| Deferred tax liabilities | 8.40%7.1M | 5.66%7.1M | 3.00%7.1M | 0.00%7.1M | -11.66%6.55M | -12.68%6.72M | -15.77%6.9M | -18.42%7.1M | -19.79%7.42M | -21.36%7.7M |
| Long term deferred income | -2.66%15M | -3.17%15.08M | -3.67%15.16M | -4.15%15.24M | -4.11%15.41M | -31.23%15.57M | -32.10%15.74M | -32.94%15.9M | -33.84%16.07M | -8.97%22.64M |
| Lease liabilities | 6.64%5.92M | 6.84%5.96M | -69.95%6.25M | -8.68%5.45M | -73.60%5.56M | -74.09%5.58M | -2.46%20.79M | -71.75%5.97M | --21.04M | --21.52M |
| Other non current liabilities | 723.87%650.31K | 723.87%650.31K | 638.09%650.31K | 723.87%650.31K | --78.93K | --78.93K | --88.11K | --78.93K | ---- | ---- |
| Total non current liabilities | 39.58%522.53M | 58.72%550.73M | 36.84%534.32M | 48.55%548.01M | -29.10%374.36M | -25.52%346.98M | -29.47%390.48M | -25.51%368.92M | 6.02%527.98M | -6.80%465.89M |
| Total liabilities | 9.20%2.35B | 14.02%2.33B | 22.67%2.5B | 26.88%2.43B | 10.73%2.16B | -22.97%2.05B | -25.09%2.03B | -26.53%1.91B | -26.21%1.95B | -1.98%2.66B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%350.34M | 0.00%350.34M | 0.00%350.34M | 0.00%350.34M | 0.00%350.34M | 0.00%350.34M | 0.00%350.34M | 0.00%350.34M | 0.00%350.34M | 0.00%350.34M |
| Capital reserve funds | 0.01%788.17M | 0.01%788.17M | 0.01%788.17M | 0.01%788.17M | -0.25%788.07M | -0.25%788.07M | -0.25%788.07M | -0.25%788.07M | 0.00%790.05M | 0.00%790.05M |
| Surplus reserve funds | 0.00%18.36M | 0.00%18.36M | 0.00%18.36M | 0.00%18.36M | 0.00%18.36M | 0.00%18.36M | -5.60%18.36M | 0.00%18.36M | 0.00%18.36M | 0.00%18.36M |
| Retained profit | -142.13%-1.14B | -193.00%-1.11B | -166.26%-1.01B | -170.08%-961.75M | -54.54%-471.94M | -1.93%-380.31M | -18.32%-379.05M | -6.99%-356.09M | -7.07%-305.39M | -25.23%-373.09M |
| Other composite income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -5.01%-143.88K |
| Specific reserves | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -42.51%555.95K |
| Shareholders equity without minority interests | -97.93%14.15M | -94.52%42.55M | -81.02%147.62M | -75.63%195.12M | -19.75%684.82M | -1.22%776.46M | -7.49%777.71M | -3.10%800.67M | -2.38%853.35M | -8.77%786.06M |
| Minority interests | -19.86%723.07M | -19.50%733.07M | -7.89%788.59M | -4.83%822.2M | 3.49%902.24M | 8.68%910.59M | 4.58%856.09M | 10.34%863.95M | 13.71%871.79M | 12.11%837.86M |
| Total shareholder equity | -53.55%737.22M | -54.03%775.62M | -42.70%936.2M | -38.89%1.02B | -8.00%1.59B | 3.89%1.69B | -1.54%1.63B | 3.44%1.66B | 5.14%1.73B | 0.93%1.62B |
| Total liabilityies and equity | -17.41%3.09B | -16.74%3.11B | -6.44%3.43B | -3.71%3.45B | 1.93%3.74B | -12.78%3.73B | -16.16%3.67B | -15.09%3.58B | -14.19%3.67B | -0.90%4.28B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | -- | -- | -- | -- | China Audit Asia Pacific Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
